Author | Year | Design of studies | Country | No. of Subjects in case group | No. of controls | Age of intervention group (mean) | Follow-up Duration (week) | Clinical Condition | Salt substitute | Salt type | Baseline BP | Quality | sex | method of measurement |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Allaert | 2013 | a randomized, placebo-controlled, double-blind, clinical trial crossover study. | France | 21 | 19 | 58.6(Total) | 8 weeks | Stage 2 of hypertension | NaCl + Chitosan 3% | NaCl | 149.2/93.4 | 3 | m/f | Blood pressure was measured using homologated automated digital sphygmomanometers. The BP cuff was placed around the upper left arm which was supported at the level of the heart while the subject sat in a chair. Blood pressure was measured after a 10-min rest and preferably at three different times separated by 3-min intervals. The average of the three measurements was calculated. |
Arzilli | 1986 | Randomized controlled trial | Italy | 5 | 5 | 39.5(Total) | 0.25 months | Stage 2 of hypertension | k/Na salt | Common salt [N/A] | > 95 |  | m/f | NS |
Barros | 2015 | Single-blind randomized controlled trial | Brazil | 19 | 16 | 55.5(total participants) | 4 weeks | Stage 2 of hypertension | 130 mg of sodium, 346 mg of potassium and 44 mcg ofiodine for per gram light salt | 390 mg of sodium and 25 mcg of iodine per gram salt | 142.95/89.79 | 5 | m/f | Casual BP was measured by the researcher. And home blood pressure use in this study |
Gilleran | 1996 | a randomised blind controlled parallel study. | United kingdom | 20 | 20 | 62.5 | 3 months | Stage 2 of hypertension and Type II diabetic | 50% NaCl, 40% KCL, 10% Mg2+ | Ordinary Table salt [N/A] | Sbp = 163.2 | NS | m/f | NS |
Pereira | 2005 | randomized, double-blind | Brazil | 12 | 10 | 47.5(Total) | 12 week | Stage 2 of hypertension | 50% sodium chloride and 50% potassium chloride | NaCl100% | 136.2/93.8 | 4 | m/f | Systolic and diastolic blood pressure values during medical consultation were determined by the auscultatory method. Measurements were made with the cuff placed covering the two thirds on the upper arm with the patient sitting, after 5 min at rest, and the values of systolic and diastolic pressure |
Sarkkinen | 2011 | Randomized, double-blind, placebo-controlled | Finland | 22 | 23 | 57 | 8 week | Stage 2 of hypertension | 50% sodium chloride (NaCl), 25% potassium chloride(KCl) and 25% magnesal; magnesium ammonium potassiumchloride, hydrate [Mg4K(NH4)3Cl12·24H2O] | NaCl100% | 140/89 | 4 | m/f | BP and heart rate were measured using an automatic sphygmomanometer (Omron M4-I, fully automatic BP monitor, Omron Matsusaka Co, Ltd., Japan) following 10 min rest in a sitting position. BP was measured three times with intervals of at least two minutes, between the hours of 7:00 am and 12:00 noon. BP was measured using the non-dominant arm with the exception of the first study visit during which BP was measured using both arms. If the BP in the two arms differed in SBP or DBP by more than 10 mmHg, the arm with the higher reading was used for all subsequent measurements. Volunteers were not told the results of their BP measurements during the study and the study nurse was unaware of the treatment allocations |
Yang (a) | 2018 | Single blind, randomized, controlled trial | China | 24 | 27 | 67.8 | 6 months | Stage 2 of hypertension | Low sodium salt [Nacl65%, Kcl30%, Ca salts5% and 12 mg/kg folic acid] | NaCl100% | 161/80.6 |  | m/f | SBP and DBP were defined by Korotkoff sound phase 1 and phase 5, respectively. |
Yang (b) | 2018 | Single blind, randomized, controlled trial | China | 38 | 37 | 67.3 | 6 months | Stage 2 of hypertension | Low sodium salt [Nacl65%, Kcl30%, Ca salts5% and 12 mg/kg folic acid] | NaCl100% | 159/85 |  | m/f | SBP and DBP were defined by Korotkoff sound phase 1 and phase 5, respectively. |
Zhao | 2014 | Patient-Blinded Randomized Controlled Trial | China | 99 | 114 | 62.8 | 3 months | Stage 2 of hypertension | 65% sodium chloride, 25%potassium chloride and 10% magnesium sulfate | NaCl100% | 174.1/102.2 | 5 | m/f | Blood pressure was measured with three consecutive blood pressure measurements (with at least one minute’s rest between each measurement) from a seated subjects’ right arm in a quiet room. A previously validated electronic sphygmomanometer (OMRON HEM-759P, Dalian China) was used. |
Zhou | 2009 | Single-blind, randomized, controlled trial | China | 62 | 64 | 67.5 | 6 months | Stage 2 of hypertension | NaCl, 65%; KCl, 30%; Calcium saits 5%; 12 mg/kg folic acid | NaCl100% | 159.7/83.3 | 4 | m/f | the measurement were performed by two experienced physicians |
Zhou | 2013 | Double-blind, randomized controlled trial | China | 224 | 238 | 46(Total) | 24 months | Stage 2 of hypertension | NaCl, 65%; KCl, 25%; MgSO4, 10% | NaCl100% | 154/91 | 5 | m/f | Blood pressure was measured at each visit by trained doctors using an Omron HEM-770A automatic sphygmomanometer (OMRON (China) Co., Ltd. (OCE/OCE-HCB/OCE-SH), Shanghai, China). Blood pressure was measured in the right arm at the heart level in the seated position. |